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nuclear proteins with regulatory functions (CBP, TATA-
BP, and EYA) have been observed in coaggregates with
expanded polyglutamines in model systems (Perez et
al., 1998; Kazantsev et al., 1999). Ubiquitin-mediated
degradation (or self-aggregation) of expanded ataxin-1
could limit its ability to bind such proteins.
A feature of both models is that neurotoxicity should
roughly correspond to the available surface area of the
misfolded and/or aggregated protein. This agrees well
with the observation that disruption of NIs can increase
toxicity. Thus, any treatment that partially disrupts the
formation or maintenance of inclusions without reducing
the mass of constituent protein would be expected to
exacerbate the disease. The most promising therapeutic
targets might therefore be misfolded protein or compo-
nents of regulatory pathways disrupted by expanded
polyglutamine repeats rather than the protein aggre-
gates themselves. However, it remains to be seen
whether such regulatory pathways can be identified and
whether this kettle of herring will at last satisfy the palate.
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ized target of E6-AP is p53. p53 is proapoptotic, and or TranSVorming Presynaptic
cell death in several polyglutamine expansion models Ca21 Sensors?is caspase dependent (Ona et al., 1999; SaÂ nchez et al.,
1999).
In Model 2, expanded polyglutamine proteins bind
other proteins necessary for cell function into a nonpro- Synaptic vesicles are the key organelles in neurotrans-
ductive complex, disrupting the balance of key cell regu- mitter release from nerve cells. Due to the ideal biochem-
lators. Polyglutamine has been described as a transcrip- ical accessibility of synaptic vesicles, most of their pro-
tein components have been purified and cloned duringtional modulator (Gerber et al., 1994), and several
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the last 15 years; one of the first such components SV2A mutants is not aggravated by additional loss of
SV2B (Janz et al., 1999). While both studies agree onbiochemically identified was SV2 (Buckley and Kelly,
the epileptic behavorial phenotype of the SV2A knock-1985). However, in the case of many synaptic vesicle
out (and in the case of Janz et al., the double SV2A/proteins, including SV2, scientific progress beyond the
SV2B knockout as well), electrophysiological analysesidentification of structures, localizations, and interaction
of synaptic transmission in the two preparations pointpartners was slow; functions for synaptic vesicle pro-
to conflicting theories for the underlying mechanism.teins remained elusive. As of today, this is no longer
One seemingly straightforward explanation for thetrue for SV2 proteins.
epileptic phenotype of SV2A knockouts emerges fromSV2 is a component of all synaptic vesicles in all verte-
analyses of spontaneous events in mutant hippocampalbrates (Lowe et al., 1988). The elucidation of the primary
slices (Crowder et al., 1999). In this preparation, spon-structure of SV2 gave rise to great hopes for a swift
taneous action potential±dependent inhibitory postsyn-determination of SV2 function in the central nervous
aptic currents (IPSCs) measured in CA3 pyramidal cellssystem. Vertebrates express a family of three SV2 iso-
from 9- to 12-day-old SV2A mutants are drastically re-forms, SV2A, SV2B, and SV2C (Bajjalieh et al., 1992,
duced in frequency and amplitude, whereas action po-1993; Feany et al., 1992; Gingrich et al., 1992). Their
tential±independent miniature IPSCs are normal (Crowderprimary structure andÐmore strikinglyÐtheir common
et al., 1999). This would indicate that loss of SV2A leadsdomain structure, with 12 potential transmembrane seg-
to a reduced efficacy of release, which then causes thements and cytoplasmic N and C termini, is reminiscent
observed seizures.of bacterial and eukaryotic transporters (Bajjalieh et al.,
However, the whole story is more complicated, as an1992; Faeny et al., 1992; Janz et al., 1998). Interestingly,
equally straightforward but different mechanistic inter-there are no invertebrate orthologs of SV2, leading to
pretation arises from the analysis of synaptic transmis-the suggestion that SV2s represent an evolutionarily late
sion in cultured hippocampal neurons. Detailed analy-aquisition of vertebrates that may originate from a dis-
ses of glutamatergic and GABAergic transmission intantly related ancestor, SVOP, that is also expressed in
cultures from SV2A and SV2B knockout mice found noC. elegans and Drosophila (Janz et al., 1998).
differences in evoked responses or short-term depres-But whatÐif anythingÐdo SV2s transport? SV2s do
sion compared to wild-type controls. Only when bothnot represent classical neurotransmitter transporters.
isoforms are deleted are mutant synapses affected, andRather, they are most closely related to prokaryotic and
even in this case it is only glutamatergic and not
eukaryotic proteins involved in facilitated ion transport
GABAergic synapses that are altered. (Janz et al., 1999).
(Janz et al., 1998). The presence of ion transporters on Despite the lack of any observable ultrastructural
synaptic vesicles has long been postulated as neces- changes in the glutamatergic synapses in the SV2A/
sary to guarantee osmotic balance and compensatory SV2B double knockout mice, synaptic trains from these
ion fluxes during neurotransmitter sequestration. How- glutamatergic cells show transient facilitation and less
ever, transport substrates of SV2s have yet to be identi- depression during repetitive stimulation at 2±10 Hz com-
fied. Indeed, SV2s may not be transporters after all. pared to wild-type controls (Janz et al., 1999). This effect
Alternative hypotheses of SV2 function include a role is reversed by EGTA-AM pretreatment, suggesting a role
for their highly glycosylated intravesicular domains in for Ca21. Janz et al. (1999) suggest that presynaptic
trapping soluble neurotransmitter molecules to diminish terminals of double mutant neurons accumulate abnor-
the intravesicular osmotic pressure, as has been ob- mally high Ca21 levels during repetitive stimulation that
served in large dense-core vesicles (Alvarez et al., 1993); can not be removed at normal rates. Thus, while the
a role in modifying synaptic vesicle exocytosis by bind- analysis of transmission in slices from SV2A knockout
ing to synaptotagmin I (Schivell et al., 1996); and a role mice suggests that seizures result from a selective defi-
as scaffold proteins that regulate vesicle shape or steps cit in inhibitory synaptic transmission (Crowder et al.,
in vesicle trafficking (Janz et al., 1998). 1999), the analysis of synaptic transmission in culture
In many cases where conventional biochemical and suggests that they arise from transiently increased excit-
cell biological attempts to determine the function of a atory activity (Janz et al., 1999).
protein have failed, genetic analyses in model organisms The above survey of key data from the two studies
have proven useful. Two studies on deletion mutant on SV2 mutant mice leaves us with one major problem:
mice now demonstrate that this is also true for SV2s. In why is GABAergic transmission in hippocampal slices
a systematic mouse genetic approach, Janz et al. (1999 from SV2A knockouts strongly reduced, while individual
[this issue of Neuron]) generated knockouts of SV2A GABAergic neurons in hippocampal primary cultures are
and SV2B, as well as SV2A/SV2B double knockouts, normal? With the available data, this problem cannot
and performed a detailed electrophysiological analysis be resolved. The two sets of data could, in principle, be
in microdot cultures of individual primary hippocampal reconciled by assuming that the reduction in GABAergic
neurons. Crowder et al. (1999) studied the phenotype transmission observed in slices is secondary to an al-
of their own line of SV2A knockouts in hippocampal tered network activity. However, the decreases in spon-
slices. The respective results are striking, and the differ- taneous IPSCs were measured in the presence of gluta-
ences between the two experimental paradigms result mate receptor blockers, indicating that the reduced
in intriguing discrepancies between the two studies. GABAergic activity may result from an intrinsic reduction
Mice lacking the most widely expressed SV2A isoform of release from GABAergic neurons. Other possible ex-
suffer from strong epileptic seizures and die within 3 planations for the discrepancy between the slice and
weeks after birth (Crowder et al., 1999; Janz et al., 1999). culture experiments would be that the GABAergic neu-
In contrast, mutants lacking SV2B, which is expressed in rons that are affected in slices do not develop in culture,
a subset of SV2A-expressing neurons, show no obvious or that cultured neurons are simply different from those
in slices.phenotypic changes, and the epileptic phenotype of
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Assuming that the somewhat contradictory findings control Ca21 levels in presynaptic terminals. Their idea
in slices and cultures can some day be reconciled, what of SV2s serving as vesicular Ca21 transporters or Ca21
then is the mechanism by which SV2 proteins alter neu- binding proteins should and can be tested directly. Also,
rotransmitter release? SV2s are not essential for synap- a quantitative analysis of absolute evoked response am-
tic transmission and do not regulate the basic vesicular plitudes to detect subtle changes in transmitter release
transmitter loading and fusion machinery (Crowder et for both glutamatergic and GABAergic cells would pro-
al., 1999; Janz et al., 1999). Janz et al. (1999) suggest vide a helpful complement to the present culture data.
that SV2s act by binding Ca21 or, more likely, by pumping On the other hand, in order to definitively conclude a
excess presynaptic Ca21 into vesicles. The conserved neurotransmitter-specific effect of the SV2A knockout,
presence of negatively charged residues in the first it would be important to complement the data by
transmembrane domain of SV2s would agree with such Crowder et al. (1999) on reduced efficacy of spontane-
a function. This hypothesis is fascinating, because it ous action potential±dependent release with an analysis
implies that synaptic vesicle SV2 acts in parallel with of evoked responses in the hippocampus.
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To interpret the data from hippocampal cultures in terms
of SV2/synaptotagmin I interactions, one would have to
propose that SV2s act as negative regulators of synapto-
tagmin I, since glutamatergic release is enhanced.
The two new papers on SV2 deletion mutant mice
make an important step toward the elucidation of SV2
function. They show that SV2A is an essential protein
(in contrast to several other synaptic vesicle compo-
nents): if you don't have it, you'll die. More impor-
tantly, fascinating models of SV2 function are presented.
Clearly, additional studies are needed to test the pro-
posed hypotheses. The studies by Janz et al. (1999) on
mutant primary neurons suggest a novel mechanism to
